Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CAD 353.72 billion. The enterprise value is 384.99 billion.

Market Cap	353.72B
Enterprise Value	384.99B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.84%
Shares Change (QoQ)	-1.02%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.72%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 17.64 and the forward PE ratio is 15.35.

PE Ratio	17.64
Forward PE	15.35
PS Ratio	4.50
PB Ratio	5.67
P/TBV Ratio	n/a
P/FCF Ratio	12.97
P/OCF Ratio	12.05
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.14, with an EV/FCF ratio of 14.12.

EV / Earnings	19.20
EV / Sales	4.97
EV / EBITDA	11.14
EV / EBIT	13.72
EV / FCF	14.12

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.

Current Ratio	0.88
Quick Ratio	0.58
Debt / Equity	0.72
Debt / EBITDA	1.27
Debt / FCF	1.64
Interest Coverage	18.35

Financial Efficiency

Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.

Return on Equity (ROE)	32.62%
Return on Assets (ROA)	12.13%
Return on Invested Capital (ROIC)	16.78%
Return on Capital Employed (ROCE)	27.17%
Revenue Per Employee	1.03M
Profits Per Employee	264,194
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 2.84 billion in taxes.

Income Tax	2.84B
Effective Tax Rate	12.40%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	23.69
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.64
Average Volume (20 Days)	1,359

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CAD 78.52 billion and earned 20.05 billion in profits. Earnings per share was 10.17.

Revenue	78.52B
Gross Profit	59.87B
Operating Income	28.49B
Pretax Income	22.87B
Net Income	20.05B
EBITDA	34.71B
EBIT	28.49B
Earnings Per Share (EPS)	10.17

Full Income Statement

Balance Sheet

The company has 13.47 billion in cash and 44.60 billion in debt, giving a net cash position of -31.14 billion.

Cash & Cash Equivalents	13.47B
Total Debt	44.60B
Net Cash	-31.14B
Net Cash Per Share	n/a
Equity (Book Value)	62.33B
Book Value Per Share	32.18
Working Capital	-5.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.35 billion and capital expenditures -2.09 billion, giving a free cash flow of 27.27 billion.

Operating Cash Flow	29.35B
Capital Expenditures	-2.09B
Free Cash Flow	27.27B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.

Gross Margin	76.25%
Operating Margin	36.29%
Pretax Margin	29.13%
Profit Margin	25.53%
EBITDA Margin	44.21%
EBIT Margin	36.29%
FCF Margin	34.73%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	54.32%
Buyback Yield	3.84%
Shareholder Yield	3.84%
Earnings Yield	5.67%
FCF Yield	7.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.

Altman Z-Score	3.8
Piotroski F-Score	7